ADPT

ADAPTIVE BIOTECHNOLOGIES COR

ADPT·00650F109·US·Common Stock·Healthcare - Biotechnology-13D/G

ADPT (ADAPTIVE BIOTECHNOLOGIES COR) is held by 154 institutional investors as of Q1 2026. Largest holders: VIKING GLOBAL INVESTORS LP ($416.3M), BlackRock, Inc. ($184.6M), VANGUARD CAPITAL MANAGEMENT LLC ($84.6M). Net institutional sentiment: Mixed.

154
Holders
(12 Elite)
$1.8B
Total Value
56% (147)
Consensus
83 buying - 64 selling
13F: Insider & Congress:
ADPTSmart Money Verdict
View all
Held by 154 funds
12 elite
Who's Trading
InsiderRSROBINS HARLAN SSell $5.2MJul 2, 2026
InsiderRSROBINS HARLAN SSell $3.3MJul 2, 2026
InsiderBSBENZENO SHARONSell $3.3MJun 29, 2026
InsiderBSBENZENO SHARONSell $232KJun 26, 2026
InsiderBSBOBULSKY SUSANSell $103KJun 25, 2026
ActivistVIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP18.8%May 15, 2026
InsiderRJRUBINSTEIN JULIEExercise 15K shApr 27, 2026
InsiderRJRUBINSTEIN JULIESell $271KApr 27, 2026
InsiderRJRUBINSTEIN JULIEExercise 15K shApr 24, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
30M$416.3M1.2%-56.40%
0
Decreased
13.3M(-0.2%)$184.6M0.0%+213.41%
0
New
6.1M$84.6M0.0%+30.97%
41
Increased
5.4M(+33.9%)$75.5M0.3%+28.93%
46
New
4.5M$62.3M0.0%+30.97%
41
Increased
4.5M(+43.2%)$61.8M0.0%+33.71%
40
Increased
3.9M(+78.2%)$53.5M0.0%+32.57%
45
Increased
3.6M(+3.5%)$50.5M0.0%+2.29%
30
Increased
3.2M(+11.7%)$45M0.0%+102.38%
33
Increased
3.2M(+1.4%)$44.8M0.0%+233.92%
30
Increased
3M(+16.5%)$41.9M0.0%+90.76%
34
New
2.7M$37.3M0.0%+30.97%
40
Decreased
2.1M(-2.1%)$29.1M0.2%+1.07%
0
Decreased
2.1M(-8.1%)$28.6M0.1%+77.04%
0
Decreased
2M(-17.6%)$27.7M0.0%+60.48%
0
Increased
2M(+3.3%)$27.3M0.0%+42.48%
30
Decreased
1.9M(-3.0%)$26.1M0.0%+28.26%
0
Decreased
1.8M(-36.6%)$24.3M0.2%+145.27%
0
Increased
1.7M(+9.8%)$23.7M0.0%+48.41%
31
Decreased
1.6M(-18.1%)$22.1M0.3%+12.91%
0

Showing 1-20 of 160

1 / 8

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used